-
While not yet available in the United States, international researchers are examining use of contraceptive progestins in two birth control methods: a transdermal patch using gestodene and an oral contraceptive formulation using dienogest.
-
What if a vaginal ring could deliver protection against unplanned pregnancy and HIV infection? Scientists are testing a ring loaded with multiple antiviral drugs to prevent HIV infection, and they also are weighing its use in pregnancy prevention.
-
Family planning clinicians have become familiar with providing Gardasil (Merck & Co.), the quadrivalent vaccine for human papillomavirus (HPV), to young women. Will their practice extend to include young men if the vaccine is approved by the Food and Drug Administration (FDA)?
-
-
In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
-
-
Although breast cancer may not be the most common cancer in women, the diagnosis or even the suspicion is a cause of great distress. Primary care physicians play a pivotal role in their female patients' care by providing the proper risk assessment, encouraging women to get the regular screening, and providing patients with the appropriate referral to definitive treatment.
-
-
A variety of highly effective agents for primary insomnia are currently available including benzodiazepines, benzodiazepine receptor agonists, and other classes. Agents that impact the benzodiazepine receptors (i.e., either benzodiazepines or benzodiazepine receptor agonists) are controlled substances and have occasional problematic issues such as misuse, diversion, cognitive clouding, and rebound upon withdrawal.
-
In elderly patients hospitalized with heart failure and LVSD, beta-blocker use was clinically effective in reducing mortality and rehospitalization, but patients with preserved systolic function had poor outcomes and beta-blockers did not significantly influence the mortality and rehospitalization rate for these patients.